Patrick Neven (P Neven)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 34

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Breast cancer research and treatment

Cancers

Cancer research communications

University Hospital Leuven

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital Leuven

Belgium

MD, PhD :: Department of Gynaecological Oncology

Publications

Javier Cortes, Sara Alsterlind Hurvitz, Joyce O'Shaughnessy, Suzette Delaloge, Hiroji Iwata, Hope S Rugo, Patrick Neven, Dheepak Kanagavel, Patrick Cohen, Gautier Paux, Sylvaine Cartot-Cotton, Maya Stefanova-Urena, Laure Deyme, Jihane Aouni, Bernard Sebastien, Aditya Bardia
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Aditya Bardia, Javier Cortes, Francois-Clement Bidard, Patrick Neven, José Angel García-Saenz, Philippe Aftimos, Joyce O'Shaughnessy, Janice Lu, Giulia Tonini, Simona Scartoni, Alessandro Paoli, Monica Binaschi, Tomer Wasserman, Virginia G Kaklamani
Elacestrant in ER+, HER2- MBC with ESR1-mutated tumors: Subgroup Analyses from the Phase III EMERALD Trial by Prior Duration of Endocrine Therapy Plus CDK4/6 Inhibitor and in Clinical Subgroups. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Maxim De Schepper, Ha-Linh Nguyen, François Richard, Louise Rosias, Florence Lerebours, Roman Vion, Florian Clatot, Anca Berghian, Marion Maetens, Sophia Leduc, Edoardo Isnaldi, Chiara Molinelli, Matteo Lambertini, Federica Grillo, Francesco Ravera, Luc Dirix, Kevin Punie, Hans P M W Wildiers, Ann Smeets, Ines Nevelsteen, Patrick Neven, Anne-Vincent Salomon, Larsimont Denis, Caroline Duhem, Patrice Viens, François Bertucci, Elia Mario Biganzoli, Peter B Vermeulen, Giuseppe Floris, Christine Desmedt
Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer-Treated with Neoadjuvant Systemic Therapy. Cancer research communications 4 (1) (2024)
Maxim De Schepper, Ha-Linh Nguyen, François Richard, Louise Rosias, Florence Lerebours, Roman Vion, Florian Clatot, Anca Berghian, Marion Maetens, Sophia Leduc, Edoardo Isnaldi, Chiara Molinelli, Matteo Lambertini, Federica Grillo, Francesco Ravera, Luc Dirix, Kevin Punie, Hans P M W Wildiers, Ann Smeets, Ines Nevelsteen, Patrick Neven, Anne-Vincent Salomon, Larsimont Denis, Caroline Duhem, Patrice Viens, François Bertucci, Elia Mario Biganzoli, Peter B Vermeulen, Giuseppe Floris, Christine Desmedt
Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer-Treated with Neoadjuvant Systemic Therapy. Cancer research communications 4 (1) (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Javier Cortes, Sara Alsterlind Hurvitz, Joyce O'Shaughnessy, Suzette Delaloge, Hiroji Iwata, Hope S Rugo, Patrick Neven, Dheepak Kanagavel, Patrick Cohen, Gautier Paux, Sylvaine Cartot-Cotton, Maya Stefanova-Urena, Laure Deyme, Jihane Aouni, Bernard Sebastien, Aditya Bardia
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (22) (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Komal L Jhaveri, Elgene Lim, Rinath M Jeselsohn, Cynthia X Ma, Erika Paige Hamilton, Cynthia Osborne, Manali Bhave, Peter A Kaufman, J Thaddeus Beck, Luis Manso Sanchez, Ritesh Parajuli, Hwei-Chung Wang, Jessica J Tao, Seock-Ah Im, Kathleen K Harnden, Kan Yonemori, Ajay Dhakal, Patrick Neven, Philippe Aftimos, Jean-Yves Pierga, Yen-Shen Lu, Timothy Larson, Yolanda Jerez, Kostandinos Sideras, Joo Hyuk Sohn, Sung-Bae Kim, Cristina Saura, Aditya Bardia, Sarah L Sammons, Francesca Bacchion, Yujia Li, Eunice Yuen, Shawn T Estrem, Vanessa Rodrik-Outmezguine, Bastien Nguyen, Roohi Ismail-Khan, Lillian M Smyth, Muralidhar Beeram
Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Maxim De Schepper, Ha-Linh Nguyen, François Richard, Louise Rosias, Florence Lerebours, Roman Vion, Florian Clatot, Anca Berghian, Marion Maetens, Sophia Leduc, Edoardo Isnaldi, Chiara Molinelli, Matteo Lambertini, Federica Grillo, Francesco Ravera, Luc Dirix, Kevin Punie, Hans P M W Wildiers, Ann Smeets, Ines Nevelsteen, Patrick Neven, Anne-Vincent Salomon, Larsimont Denis, Caroline Duhem, Patrice Viens, François Bertucci, Elia Mario Biganzoli, Peter B Vermeulen, Giuseppe Floris, Christine Desmedt
Treatment response, tumor infiltrating lymphocytes and clinical outcomes in inflammatory breast cancer treated with neoadjuvant systemic therapy. Cancer research communications (2023)
Maxim De Schepper, Ha-Linh Nguyen, François Richard, Louise Rosias, Florence Lerebours, Roman Vion, Florian Clatot, Anca Berghian, Marion Maetens, Sophia Leduc, Edoardo Isnaldi, Chiara Molinelli, Matteo Lambertini, Federica Grillo, Francesco Ravera, Luc Dirix, Kevin Punie, Hans P M W Wildiers, Ann Smeets, Ines Nevelsteen, Patrick Neven, Anne-Vincent Salomon, Larsimont Denis, Caroline Duhem, Patrice Viens, François Bertucci, Elia Mario Biganzoli, Peter B Vermeulen, Giuseppe Floris, Christine Desmedt
Treatment response, tumor infiltrating lymphocytes and clinical outcomes in inflammatory breast cancer treated with neoadjuvant systemic therapy. Cancer research communications (2023)
Yentl Lambrechts, Sigrid Hatse, François Richard, Bram Boeckx, Giuseppe Floris, Christine Desmedt, Ann Smeets, Patrick Neven, Diether Lambrechts, Hans P M W Wildiers
Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors. Cancers 15 (17) (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment 204 (2) (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment 204 (2) (2023)
Johanna E J Jacobs, Wouter L'Hoyes, Lieselotte Lauwens, Yu-Ling Yu, Marius Brusselmans, Caroline Weltens, Jens Uwe Voigt, Hans P M W Wildiers, Patrick Neven, Joerg Herrmann, Lutgarde Thijs, Jan A Staessen, Stefan P Janssens, Lucas N L Van Aelst
Mortality and Major Adverse Cardiac Events in Patients With Breast Cancer Receiving Radiotherapy: The First Decade. Journal of the American Heart Association (2023)
Maxim De Schepper, Ha-Linh Nguyen, François Richard, Louise Rosias, Florence Lerebours, Roman Vion, Florian Clatot, Anca Berghian, Marion Maetens, Sophia Leduc, Edoardo Isnaldi, Chiara Molinelli, Matteo Lambertini, Federica Grillo, Francesco Ravera, Luc Dirix, Kevin Punie, Hans P M W Wildiers, Ann Smeets, Ines Nevelsteen, Patrick Neven, Anne-Vincent Salomon, Larsimont Denis, Caroline Duhem, Patrice Viens, François Bertucci, Elia Mario Biganzoli, Peter B Vermeulen, Giuseppe Floris, Christine Desmedt
Treatment response, tumor infiltrating lymphocytes and clinical outcomes in inflammatory breast cancer treated with neoadjuvant systemic therapy. Cancer research communications (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment 204 (2) (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment 204 (2) (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment (2023)
Hanne Lefrère, Kat S Moore, Giuseppe Floris, Joyce Sanders, Iris M Seignette, Tycho Bismeijer, Dennis Peters, Annegien Broeks, Erik Hooijberg, Kristel Van Calsteren, Patrick Neven, Ellen Warner, Fedro Alessandro Peccatori, Sibylle Loibl, Charlotte Maggen, Sileny N Han, Katarzyna Joanna Jerzak, Daniela Annibali, Diether Lambrechts, Karin E de Visser, Lodewyk F A Wessels, Liesbeth Lenaerts, Frédéric Amant
Poor outcome in postpartum breast cancer patients is associated with distinct molecular and immunological features. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Céline Clement, Lieve Schops, Ines Nevelsteen, Soetkin Thijssen, Chantal Van Ongeval, Machteld Keupers, Renate Prevos, Valerie Celis, Patrick Neven, Sileny Han, Annouschka Laenen, Ann Smeets
Retrospective Cohort Study of Practical Applications of Paramagnetic Seed Localisation in Breast Carcinoma and Other Malignancies. Cancers 14 (24) (2022)
Céline Clement, Lieve Schops, Ines Nevelsteen, Soetkin Thijssen, Chantal Van Ongeval, Machteld Keupers, Renate Prevos, Valerie Celis, Patrick Neven, Sileny Han, Annouschka Laenen, Ann Smeets
Retrospective Cohort Study of Practical Applications of Paramagnetic Seed Localisation in Breast Carcinoma and Other Malignancies. Cancers 14 (24) (2022)
Céline Clement, Lieve Schops, Ines Nevelsteen, Soetkin Thijssen, Chantal Van Ongeval, Machteld Keupers, Renate Prevos, Valerie Celis, Patrick Neven, Sileny Han, Annouschka Laenen, Ann Smeets
Retrospective Cohort Study of Practical Applications of Paramagnetic Seed Localisation in Breast Carcinoma and Other Malignancies. Cancers 14 (24) (2022)
Annemarie Coolbrandt, K Vancoille, E Dejaeger, H Peeters, A Laenen, Patrick Neven, Kevin Punie, Hans P M W Wildiers
Preventing taxane-related peripheral neuropathy, pain and nail toxicity: a prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast cancer. Breast cancer research and treatment 192 (2) (2022)
S Thijssen, Hans P M W Wildiers, Kevin Punie, Benoit Beuselinck, P Clement, C Remmerie, P Berteloot, Sileny N Han, Els Van Nieuwenhuysen, Toon Van Gorp, Ignace Vergote, Ann Smeets, Ines Nevelsteen, Giuseppe Floris, Caroline Weltens, Johan Menten, H Janssen, A Laenen, Patrick Neven
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort. Journal of cancer research and clinical oncology 147 (4) (2021)
Annemarie Coolbrandt, A T'Jonck, K Blauwens, E Dejaeger, Patrick Neven, Kevin Punie, K Vancoille, Hans P M W Wildiers
Scalp cooling in breast cancer patients treated with docetaxel-cyclophosphamide: patient- and nurse-reported results. Breast cancer research and treatment 186 (3) (2021)
Eirini Thanopoulou, Leila Khader, Morena Caira, Andrew M Wardley, Johannes Ettl, Federica Miglietta, Patrick Neven, Valentina Guarneri
Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current Literature. Cancers 12 (11) (2020)
Katleen Van der Gucht, Soumaya Ahmadoun, Michelle Melis, Ellen de Cloe, Charlotte Sleurs, Ahmed Mohamed Radwan, Jeroen Blommaert, Keisuke Takano, Mathieu Vandenbulcke, Hans P M W Wildiers, Patrick Neven, Peter Kuppens, Filip Raes, Ann Smeets, Stefan Sunaert, Sabine Deprez
Effects of a mindfulness-based intervention on cancer-related cognitive impairment: Results of a randomized controlled functional magnetic resonance imaging pilot study. Cancer 126 (18) (2020)
Elisa Van Raemdonck, G Floris, P Berteloot, A Laenen, I Vergote, H Wildiers, K Punie, Patrick Neven
Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancer. Breast cancer research and treatment 185 (1) (2020)
Valerie Vandeweerd, Machteld Keupers, Griet Hoste, Tom Langenaeken, Patrick Neven
Juvenile Papillomatosis: A Case Report. European journal of breast health 15 (2) (2019)
Patrick Neven, K Punie, H Wildiers, N Willers, C Van Ongeval, G Van Buggenhout, E Legius
Risk-reducing mastectomy in BRCA carriers: survival is not the issue. Breast cancer research and treatment 179 (1) (2019)

Patrick Neven.css-eqlu8i{font-size:small;padding-left:4px;} (P Neven)

Publication Activity (10 Years)

Top Topics

Top Venues

Patrick Neven (P Neven)